Clover Biopharmaceuticals, Ltd. (HKG:2197)

Clover Biopharmaceuticals Revenue

Clover Biopharmaceuticals had revenue of 179.00K CNY in the half year ending June 30, 2026. This brings the company's total for the last twelve months to 430.00K, down -99.17% year-over-year. In the year 2025, Clover Biopharmaceuticals had annual revenue of 3.51M, down -90.88%. That makes Clover Biopharmaceuticals the 46,391st largest company in the world by revenue and 2,605th in Hong Kong.

• Revenue (ttm): 430.00K CNY
• Revenue Growth: -99.17%
• P/S Ratio: 3,884.07
• Revenue / Employee: 1.67K CNY
• Employees: 257
• Market Cap: 1.74B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• Mainland China 35.18M 91.6%
• Korea 3.24M 8.4%

Fiscal year ended Dec 31, 2024 See the full Clover Biopharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.51M	-34.91M	-90.88%
Dec 31, 2024	38.42M	-836.00K	-2.13%
Dec 31, 2023	39.26M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 19, 2026

Data Sources Report a data error